Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance
Tyrosine kinase inhibitors are a class of chemotherapeutic drugs that target specific protein kinases. These tyrosine kinase inhibitors constitute a relatively new class of drugs which target for instance Bcr-Abl, Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Recepto...
Main Authors: | Daniel J. de Klerk, Richard J. Honeywell, Gerrit Jansen, Godefridus J. Peters |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/10/12/503 |
Similar Items
-
Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration
by: Maria Krchniakova, et al.
Published: (2020-04-01) -
Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
by: Nagaraju Anreddy, et al.
Published: (2014-09-01) -
Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance
by: Yi-Jun Wang, et al.
Published: (2014-09-01) -
The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance
by: Eliska Ruzickova, et al.
Published: (2019-10-01) -
Subcellular localization of several structurally different tyrosine kinase inhibitors
by: Richard Honeywell, et al.
Published: (2018-09-01)